{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:26:13Z","timestamp":1752549973292},"reference-count":88,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>The study was conducted to assess and compare the overall diagnostic value of positron emission tomography (PET) alone and PET\/computed tomography (CT) for the detection of recurrent\/metastatic ovarian cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic literature search in PubMed, EMBASE and Chinese literature databases (CNKI, VIP and Wanfang) up to August 2014 was performed to identify relevant articles. The diagnostic performance of PET alone or PET\/CT was assessed in terms of the following evaluation indexes: summary sensitivity, specificity, positive and negative likelihood ratio, diagnostic odds ratio and area under the curve summary receiver operating characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sixty\u2010four studies with 3722 patients were included in this meta\u2010analysis. Favorable results were obtained for both PET\/CT and PET alone with similar sensitivity, specificity, positive and negative likelihood ratios, diagnostic odds ratio and area under the curve in diagnosing recurrent\/metastatic ovarian cancer (<jats:italic>P<\/jats:italic> &gt; 0.05). However, the sensitivity of PET\/CT was significantly higher than PET alone in European patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Both PET and PET\/CT have promising diagnostic value in recurrent\/metastatic ovarian cancer. The diagnostic performance of PET\/CT may be superior to PET alone in European patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jog.13222","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T02:27:37Z","timestamp":1486002457000},"page":"378-386","source":"Crossref","is-referenced-by-count":10,"title":["Diagnostic value of positron emission tomography (PET) and PET\/computed tomography in recurrent\/metastatic ovarian cancer: A meta\u2010analysis"],"prefix":"10.1111","volume":"43","author":[{"given":"Bo","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojing","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingliang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,2]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20073"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2014.04.006"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2008.02.019"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.12.007"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1157\/13073787"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057257"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.3843"},{"issue":"1","key":"e_1_2_5_9_1","first-page":"4S","article-title":"PET\/CT today and tomorrow","volume":"45","author":"Townsend DW","year":"2004","journal-title":"J Nucl Med"},{"key":"e_1_2_5_10_1","first-page":"1369","article-title":"A combined PET\/CT scanner for clinical oncology","volume":"41","author":"Beyer T","year":"2000","journal-title":"J Nucl Med"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2011.01.112"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2005.08.004"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31828a183c"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-8633-6_28"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-88-470-5385-4_41"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-010-0449-8"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1148\/rg.312105713"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.2010.05599.x"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLE.0b013e31828e3e6e"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e31825b2583"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-3-25"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5877(00)00115-X"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.2307\/2533446"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-6-31"},{"key":"e_1_2_5_26_1","first-page":"77","article-title":"The role of 18F\u2010FDG PET imaging in monitoring recurrent and metastatic ovarian cancer","volume":"23","author":"Wuying C","year":"2003","journal-title":"Chin J Nucl Med"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.179.2.1790391"},{"key":"e_1_2_5_28_1","first-page":"667","article-title":"Role of positron emission tomography in diagnosis of recurrent ovarian cancer","volume":"38","author":"Ding X","year":"2003","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0366-9"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1993.1268"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1367-y"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s003300051000"},{"key":"e_1_2_5_33_1","first-page":"366","article-title":"Value of 18F\u2010FDG PET in Diagnosing Metastatic and Recurrent Ovarian Cancer","volume":"42","author":"Liu WY","year":"2013","journal-title":"J China Med Univ"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00471.x"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.176.6.1761449"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-005-0489-6"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-001-0750-9"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6386"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181e82a7f"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1416-2"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.06.019"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000051"},{"key":"e_1_2_5_43_1","first-page":"376","article-title":"Value of 18F\u2010FDG PET\/CT in detecting the recurrence or metastasis of postoperative ovarian cancer","volume":"19","author":"Chen X","year":"2013","journal-title":"Chin Comput Med Imag"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0260-x"},{"key":"e_1_2_5_45_1","first-page":"17","article-title":"The Value of 18F\u2010FDG PET\/CT imaging in the follow\u2010up of ovarian cancer after surgery and the relationship between PET, CT imaging and serum CAl25 assay","volume":"23","author":"Deng ZY","year":"2012","journal-title":"J Chin Clin Med Imaging"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.1075"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1159\/000159266"},{"key":"e_1_2_5_48_1","first-page":"55","article-title":"18 F\u2010FDG PET\/CT imaging for monitoring the clinical value of ovarian cancer patients with postoperative recurrence\/metastasis were analyzed","volume":"51","author":"Guo J","year":"2011","journal-title":"Shandong Medical Journal"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2005.04.006"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2013.12.006"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32831089cb"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-011-0115-7"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/rct.0b013e31803e8c45"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e31826390ec"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0776-3"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2012.03.020"},{"key":"e_1_2_5_57_1","first-page":"2303","article-title":"PET\u2010CT in recurrent ovarian cancer: Impact on treatment planning","volume":"28","author":"Lenhard MS","year":"2008","journal-title":"Anticancer Res"},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2008.05.006"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.4236\/jct.2013.41A001"},{"key":"e_1_2_5_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0306-0"},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2005.02.029"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1568-0"},{"key":"e_1_2_5_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-010-0468-9"},{"key":"e_1_2_5_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1404-6"},{"key":"e_1_2_5_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-003-0118-7"},{"key":"e_1_2_5_66_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2010.0872"},{"key":"e_1_2_5_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181a3cc94"},{"key":"e_1_2_5_68_1","first-page":"22","article-title":"Role of 18F\u2010FDG PET\/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca\u2010125","volume":"33","author":"Rubini G","year":"2014","journal-title":"Rev Esp Med Nucl"},{"key":"e_1_2_5_69_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10092279"},{"key":"e_1_2_5_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32834fc5bf"},{"key":"e_1_2_5_71_1","first-page":"3","article-title":"The role of FDG\u2010PET\/CT in ovarian cancer patients with high tumor markers or suspicious lesion on contrast\u2010enhanced CT in evaluation of recurrence and\/or in determination of intraabdominal metastases","volume":"31","author":"Sari O","year":"2012","journal-title":"Rev Esp Med Nucl"},{"key":"e_1_2_5_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-007-9218-0"},{"key":"e_1_2_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.03.004"},{"key":"e_1_2_5_74_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2332031800"},{"key":"e_1_2_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.02.008"},{"key":"e_1_2_5_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.10.060"},{"key":"e_1_2_5_77_1","first-page":"439","article-title":"Value of 18F\u2010FDP PET\/CT in follow\u2010up of ovarian cancer patients after therapy","volume":"18","author":"Tong LJ","year":"2012","journal-title":"Chin Comput Med Imag"},{"key":"e_1_2_5_78_1","first-page":"788","article-title":"Joint tumor markers PET\u2010CT diagnostic value of ovarian epithelial carcinoma recurrence","volume":"13","author":"Wang Z","year":"2011","journal-title":"Journal of Chinese Physician"},{"key":"e_1_2_5_79_1","first-page":"1451","article-title":"Value of 18F\u2013FDG PET\/CT in the follow\u2010up and clinical\u2010decision of postoperation patients with epithelial ovarian cancer","volume":"27","author":"Xi JJ","year":"2011","journal-title":"Chin J Med Imaging Technol"},{"key":"e_1_2_5_80_1","first-page":"745","article-title":"The role of 18 F\u2010Fluorodexyglucose PET\u2010CT imaging in monitoring recurrent and metastastic ovarian cancer","volume":"43","author":"Zhang CQ","year":"2005","journal-title":"Journal of Shandong University (Health Sciences)"},{"key":"e_1_2_5_81_1","first-page":"187","article-title":"Value of 18F\u2010FDG PET\/CT imaging in detection of postoperative recurrent or metastasis of ovarian cancer","volume":"16","author":"Zhao J","year":"2007","journal-title":"Chinese Journal of Oncology"},{"key":"e_1_2_5_82_1","first-page":"194","article-title":"The clinical application value of PET\u2010CT in the diagnosis of ovarian cancer","volume":"11","author":"Zhu JF","year":"2013","journal-title":"Guide of China Medicine"},{"key":"e_1_2_5_83_1","first-page":"52","article-title":"[Joint of 18F\u2010FDG PET\/CT imaging and serum CA125 detection in the diagnosis of postoperative recurrence and metastasis of ovarian cancer","volume":"51","author":"Zhu YJ","year":"2011","journal-title":"Shandong Medical Journal"},{"key":"e_1_2_5_84_1","first-page":"238","article-title":"The value of 18FDG\\CT imaging in the evaluation of follow\u2010up analysis and prognosis of ovarian cancer","volume":"13","author":"Pan JY","year":"2013","journal-title":"World Latest Medicine Information"},{"key":"e_1_2_5_85_1","first-page":"623","article-title":"The applications of PET in clinical oncology","volume":"32","author":"Strauss LG","year":"1991","journal-title":"J Nucl Med"},{"key":"e_1_2_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1095-0397(97)00004-6"},{"key":"e_1_2_5_87_1","doi-asserted-by":"publisher","DOI":"10.1148\/rg.232025705"},{"key":"e_1_2_5_88_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2312021185"},{"key":"e_1_2_5_89_1","first-page":"492","article-title":"The utility of positron emission tomography in ovarian cancer","volume":"84","author":"Naumann R","year":"2002","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjog.13222","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jog.13222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T08:38:21Z","timestamp":1696235901000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/jog.13222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1111\/jog.13222"],"URL":"https:\/\/doi.org\/10.1111\/jog.13222","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}